Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2004

01-01-2004

Fatigue, Weight Gain, Lethargy and Amenorrhea in Breast Cancer Patients on Chemotherapy: Is Subclinical Hypothyroidism the Culprit?

Authors: Nagi Kumar, Kathryn A. Allen, Diane Riccardi, Barry B. Bercu, Alan Cantor, Sue Minton, Lodovico Balducci, Paul B. Jacobsen

Published in: Breast Cancer Research and Treatment | Issue 2/2004

Login to get access
Metadata
Title
Fatigue, Weight Gain, Lethargy and Amenorrhea in Breast Cancer Patients on Chemotherapy: Is Subclinical Hypothyroidism the Culprit?
Authors
Nagi Kumar
Kathryn A. Allen
Diane Riccardi
Barry B. Bercu
Alan Cantor
Sue Minton
Lodovico Balducci
Paul B. Jacobsen
Publication date
01-01-2004
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/2004
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/B:BREA.0000010708.99455.e1

Other articles of this Issue 2/2004

Breast Cancer Research and Treatment 2/2004 Go to the issue

OriginalPaper

Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Erratum

Breast Cancer in Women with Human Immunodeficiency Virus Infection: Implications for Diagnosis and Therapy

OriginalPaper

Incremental Diagnostic Value of Quantitative Analysis of Double Phase Tc-99m MIBI Scintimammography for the Detection of Primary Breast Cancer Additive to Visual Analysis

OriginalPaper

Calcitonin Receptor Gene and Breast Cancer: Quantitative Analysis with Laser Capture Microdissection

OriginalPaper

Altered Expression and Activation of the Nerve Growth Factor Receptors TrkA and p75 Provide the First Evidence of Tumor Progression to Effusion in Breast Carcinoma

OriginalPaper

Partially Unspliced and Fully Spliced ELF3 mRNA, Including a New Alu Element in Human Breast Cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits